MARK L SMITH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK L SMITH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK L SMITH. MARK L SMITH is a Sr. VP Fin., CFO, CAO & Treas. in Aviragen Therapeutics, Inc. ($NABI) and a Sr. VP. Fin., CFO, CAO &Treas. in Aviragen Therapeutics, Inc. ($NABI) and a Sr.VP. Fin., CFO, CAO & Treas. in Aviragen Therapeutics, Inc. ($NABI).
Address: C/O NABI BIOPHARMACEUTICALS 5800 PARK OF COMMERCE BLVD., N.W. BOCA RATON 33487 FL
Companies in which MARK L SMITH is an Insider
Vaxart, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MARK L SMITH: Sr.VP. Fin., CFO, CAO & Treas., Sr. VP. Fin., CFO, CAO &Treas., Sr. VP Fin., CFO, CAO & Treas.
Holdings: 17,393 shares
Current Value: $19,828
Latest Transaction: Nov 10 2005
$VXRT Market Capitalization: $43.28M
$VXRT Previous Close: $1.14
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MARK L SMITH
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10 2005 | NABI | Aviragen Therapeut ... | SMITH MARK L | Sr. VP Fin., CFO, C ... | Buy | I | 3.52 | 17,393 | 61,136 | 17,393 | 0 to 17.4 K |
| Sep 15 2005 | NABI | Aviragen Therapeut ... | SMITH MARK L | Sr. VP Fin., CFO, C ... | Buy | J | 10.58 | 1,228 | 12,995 | 19,908 | 18.7 K to 19.9 K (+6.57 %) |
| Mar 16 2005 | NABI | Aviragen Therapeut ... | SMITH MARK L | Sr. VP Fin., CFO, C ... | Option Exercise | A | 12.06 | 75,000 | 904,500 | 75,000 | |
| Jun 22 2004 | NABI | Aviragen Therapeut ... | SMITH MARK L | Sr.VP. Fin., CFO, C ... | Buy | J | 9.23 | 1,337 | 12,342 | 17,623 | 16.3 K to 17.6 K (+8.21 %) |
| May 18 2004 | NABI | Aviragen Therapeut ... | SMITH MARK L | Sr.VP. Fin., CFO, C ... | Option Exercise | A | 16.65 | 10,472 | 174,359 | 10,472 | |
| Mar 26 2004 | NABI | Aviragen Therapeut ... | SMITH MARK L | Sr. VP. Fin., CFO, ... | Option Exercise | A | 14.92 | 43,994 | 656,390 | 43,994 | |
| Feb 06 2004 | NABI | Aviragen Therapeut ... | SMITH MARK L | Sr. VP Fin., CFO, C ... | Buy | J | 5.94 | 1,949 | 11,580 | 16,286 | 14.3 K to 16.3 K (+13.59 %) |